Medicare Enrolled

Dr. Radha Tamerisa, M.D.

Gastroenterology · Katy, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
25230 KINGSLAND BLVD STE 102, Katy, TX 77494
2818693009
In practice since 2005 (20 years)
NPI: 1366440653 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tamerisa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tamerisa? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tamerisa

Dr. Radha Tamerisa is a gastroenterology in Katy, TX, with 20 years in practice. Based on federal Medicare data, Dr. Tamerisa performed 1,599 Medicare services across 765 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tamerisa received a total of $111,005 from 56 pharmaceutical and/or device companies across 915 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tamerisa is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 11% volume in TX$ $111,005 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,599
Medicare services
Top 11% in TX for gastroenterology
765
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~80 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)607$83$280
Tissue pathology examination, moderate complexity391$25$249
Special stained specimen slides to examine tissue including interpretation and report165$51$232
Special stained specimen slides to identify organisms including interpretation and report154$63$333
Colonoscopy with biopsy86$126$931
Office visit, established patient (20-29 min)76$59$182
Upper GI endoscopy with biopsy62$73$830
New patient office visit (45-59 min)32$110$465
Removal of polyps or growths of large bowel using an endoscope with mechanical snare26$209$1,106
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$111,005
Total received (2018-2024)
Avg $15,858/year across 7 years
Top 3% in TX for gastroenterology
56
Companies
915
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90,029 (81.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,025 (13.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,951 (5.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$22,864
2023
$15,998
2022
$44,010
2021
$21,979
2020
$1,906
2019
$2,016
2018
$2,232

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$51,530
ABBVIE INC.
$17,536
RedHill Biopharma Inc.
$16,007
AbbVie Inc.
$8,251
Celgene Corporation
$3,483
Janssen Scientific Affairs, LLC
$2,330
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,592
AbbVie, Inc.
$1,232
Janssen Biotech, Inc.
$1,064
Takeda Pharmaceuticals U.S.A., Inc.
$996
PFIZER INC.
$827
Romark Laboratories, LC
$587
QOL Medical, LLC
$522
Medtronic, Inc.
$405
Regeneron Healthcare Solutions, Inc.
$336
Ardelyx, Inc.
$302
Merck Sharp & Dohme LLC
$290
Madrigal Pharmaceuticals
$284
Synergy Pharmaceuticals Inc
$278
Braintree Laboratories, Inc.
$269
Phathom Pharmaceuticals, Inc.
$246
VIVUS LLC
$226
Gilead Sciences, Inc.
$211
Ironwood Pharmaceuticals, Inc
$180
GENZYME CORPORATION
$161
Nestle HealthCare Nutrition Inc.
$136
Merck Sharp & Dohme Corporation
$130
Abbott Laboratories
$127
Amgen Inc.
$126
Prometheus Laboratories Inc.
$120
ALCRESTA THERAPEUTICS, INC.
$117
Allergan Inc.
$116
Intercept Pharmaceuticals, Inc.
$108
INTERCEPT PHARMACEUTICALS, INC.
$103
Allergan, Inc.
$90
Lucid Diagnostics Inc.
$69
Lilly USA, LLC
$68
Exact Sciences Corporation
$58
Celltrion USA Inc.
$55
Concordia Pharmaceuticals Inc.
$53
Endogastric Solutions, Inc
$50
Alfasigma USA, Inc.
$49
AIMMUNE THERAPEUTICS, INC.
$35
Pharmacosmos Therapeutics Inc.
$31
Ambu Inc.
$24
Amarin Pharma Inc.
$22
UCB, Inc.
$22
NESTLE HEALTHCARE NUTRITION INC.
$21
Endo Pharmaceuticals Inc.
$21
Ferring Pharmaceuticals Inc.
$20
Daiichi Sankyo Inc.
$20
Shire North American Group Inc
$20
Alnylam Pharmaceuticals Inc.
$18
ERBE USA Inc
$14
Ethicon US, LLC
$14
Napo Pharmaceuticals Inc
$2
Top 3 companies account for 76.6% of total payments
Associated products mentioned in payments ›
ALINIA · AMJEVITA · APC2 · APRISO · AVSOLA · Alinia · Alinia Tablets 500mg 30 count bottle · CIMZIA · CREON · CYCLOSET · Cimzia · Cologuard Collection Kit · Creon · DIFICID · DONNATAL · DUPIXENT · ENDOFLIP · ENTYVIO · ESOPHYX · Entyvio · GATTEX · GI GENIUS · HUMIRA · Humira · IBSRELA · INFLECTRA · LINZESS · Linzess · MAVYRET · MONOFERRIC · MOTEGRITY · MOTOFEN · Mavyret · Mitra Clip system · Motegrity · Movantik · Mytesi · NASCOBAL · OCALIVA · OMVOH · ONPATTRO · PANCREAZE · PILLCAM · QSYMIA · Qsymia · RELISTOR · RELISTOR ORAL · RELIZORB · REMICADE · RESMETIROM · REZDIFFRA · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP · SUPREP BOWEL PREP · SUTAB · Sucraid · TALICIA · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS · VEGZELMA · VELSIPITY · VIBERZI · VOQUEZNA · VOWST · VRAYLAR · Vascepa · XELJANZ · XIFAXAN · XIFAXANIBSD · XIFIXAN · ZENPEP · ZEPOSIA · ZYMFENTRA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (81%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for gastroenterology in TX.

Equivalent to $6,942 per 100 Medicare services performed
Looking for a gastroenterology in Katy?
Compare gastroenterologys in the Katy area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
203
Per 100K population
23.6
County median income
$113,409
Nearest hospital
MEMORIAL HERMANN KATY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Tamerisa is a clinical cardiology specialist, with above-average Medicare volume (top 11% in TX), and high industry engagement (speaking/promotional, top 3%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Tamerisa experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Tamerisa performed 607 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tamerisa receive payments from pharmaceutical companies?
Yes. Dr. Tamerisa received a total of $111,005 from 56 companies across 915 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tamerisa's costs compare to other gastroenterologys in Katy?
Dr. Tamerisa's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tamerisa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →